Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Filter Results By

Filter Applied. Clear All
Reset All Filters
CLI Leadership & Staff

Ingrid Skop, M.D., FACOG

Vice President and Director of Medical Affairs

Ingrid Skop, M.D., FACOG, is Vice President and Director of Medical Affairs for Charlotte Lozier Institute, leveraging more than 30 years’ experience as a practicing obstetrician-gynecologist to support research and policies that respect the dignity of every human life.

Dr. Skop received her Bachelor of Science in physiology from Oklahoma State University and her medical doctorate from Washington University School of Medicine. She completed her residency in obstetrics and gynecology at the University of Texas Health Science Center at San Antonio. Dr. Skop is a Fellow of the American College of Obstetricians and Gynecologists, where she uses science and statistics to counter pro-abortion agendas, and is a lifetime member of the American Association of Pro-Life Obstetricians and Gynecologists.

Prior to joining Charlotte Lozier Institute, Dr. Skop served for over 25 years in private practice in San Antonio, where she delivered more than 5,000 babies and personally cared for many women who had been harmed, physically and emotionally, from complications due to abortion. She has served as board member and medical director for pregnancy resource centers in San Antonio, Austin, and Houston. 

Dr. Skop’s research on maternal mortality, abortion, and women’s health has been published in multiple peer-reviewed journals. Additionally, she has provided expert testimony at both the state and federal levels on legislation related to abortion, including standing firm against prominent pro-abortion politicians who choose not to follow the science regarding fetal heartbeat and development.

Dr. Skop is married to a physician and is the proud mother of two sons and a daughter.

To learn more about Dr. Ingrid Skop’s journey as a pro-life obstetrician-gynecologist, please watch this video:

Research Authored

Maternal & Public Health

Handbook of Maternal Mortality: Addressing the U.S. Maternal Mortality Crisis, Looking Beyond Ideology

After years of failure to obtain accurate statistics on maternal mortality, researchers noted a sharp increase in the United States’ maternal mortality with widening racial disparities. Much discussion has followed about possible etiologies of the rise, but the existence of severe deficiencies in data collection and analysis is agreed upon by all.

featured-image
Maternal & Public Health

Immediate Physical Complications of Induced Abortion

To reach accurate conclusions regarding physical complications following abortion, an observer must view the abortion industry’s claims with skepticism and seek additional information to find the truth. Any abortion can result in complications, particularly if performed by a poorly skilled or otherwise compromised abortionist.

Maternal & Public Health

Induced Abortion with Misoprostol Alone

As abortion limits have been implemented in many states in the wake of the Supreme Court’s Dobbs decision, some perplexing recommendations have been advanced by abortion advocates and their media allies. 

featured-image
Maternal & Public Health

Chemical Abortion: Risks Posed by Changes in Supervision

Although U.S. chemical abortion complication data is difficult to obtain due to voluntary reporting and other known deficiencies in data collection, better quality international data indicates that complications occur relatively frequently, with 3-8% of women requiring surgical completion. 

featured-image
Maternal & Public Health

A Post Hoc Exploratory Analysis: Induced Abortion Complications Mistaken for Miscarriage in the Emergency Room are a Risk Factor for Hospitalization

Previous research indicates that an increasing number of women who go to an emergency room for complications following an induced abortion are treated for a miscarriage, meaning their abortion is miscoded or concealed.

featured-image
Maternal & Public Health

Fact Sheet: Medical Indications for Separating a Mother and Her Unborn Child

There are humane medical interventions that aim for both mother and her unborn child to live when possible and do not inflict direct violence on the unborn child.

Maternal & Public Health

No-Test Chemical Abortion Provision: Can it be Justified?

Many undocumented assumptions have been made to portray unsupervised, “self-managed” medical abortion as safe. These erroneous conclusions will, in fact, cause the procedure to become more dangerous for a woman seeking abortion, and will be addressed below.

Maternal & Public Health

The Evolution of “Self-Managed” Abortion: Does the Safety of Women Seeking Abortion Even Matter Anymore?

A particularly malignant form of “misinformation” is being spread to women today.  Flawed information regarding “self-managed” abortion has the potential to seriously injure the women I care for as an obstetrician/gynecologist.

Maternal & Public Health

Overlooked Dangers of Mifepristone, the FDA’s Reduced REMS, and Self-Managed Abortion Policies: Unwanted Abortions, Unnecessary Abortions, Unsafe Abortions

The failure of abortion providers to support and undertake prospective longitudinal studies of a nationally representative sample of women contributes to our belief that the ideological biases of abortion providers have led to a combination of disinterest, willful ignorance, or even a conspiracy to hide the widespread dangers of unwanted and contraindicated abortions.

featured-image
Maternal & Public Health

A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999–2015

Existing research on postabortion emergency room visits is sparse and limited by methods which underestimate the incidence of adverse events following abortion. Postabortion emergency room (ER) use since Food and Drug Administration approval of chemical abortion in 2000 can identify trends in the relative morbidity burden of chemical versus surgical procedures.